- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Windlas Biotech reported record revenue of ₹248 Cr (up 18% YoY). Adjusted EBITDA grew 26% to ₹34 Cr, PAT 37% to ₹25 Cr. Company completed a ₹47 Cr share buyback and paid ₹13 Cr dividend for FY26. Plant-6 commercialization is on track.